We next analyzed patterns of gene expression in the cell subgroups defined using the surface expression of CCR6 and CCR2 (regardless of cluster designation), analogous to the way we characterized cells from the blood of healthy donors and compared the data from cells from MS patients versus cells from control participants (Fig. 3h). This evidence concerns the gene CCR6 and myeloid sarcoma.